Figure 3

Comparative-KC-SMART analysis of aCGH data from luminal breast tumors. The luminal-H tumor group was divided into 8 TP53-mutated tumors and 23 TP53 wild-type tumors. KSE curves of the TP53-mutated tumors (blue) and the TP53 wild-type tumors (gray) are shown for gains and losses separately. Comparative-KC-SMART analysis did not detect significant differences between the two tumor groups.